A Study of Emapalumab for Pediatric Aplastic Anemia

Clinical trial NCT06430788 · RECRUITING

Trial details

NCT number: NCT06430788
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Aplastic Anemia Cytopenia Hypocellular Marrow

Start date: 2024-05-21
Primary completion: 2029-05-21
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.